Christopher D. Verrico, PhD
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher D. Verrico, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:30 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07218549 · Evaluation of the Safety and Effects of Psychoactive Substances in People With Past Opioid UseChristopher D. Verrico · recruiting · Opioid Use, Substance Use Disorders, Opioid Analgesia
- Ph2NCT06454669 · Dronabinol as an Adjunct for Reducing PainChristopher D. Verrico · recruiting · Low Back Pain, Chronic Pain, Back Injuries
- Ph1NCT06252623 · Exenatide For Reducing the Reinforcing Effects of CocaineChristopher D. Verrico · withdrawn · Cocaine Use Disorder
- Ph2NCT04360681 · Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in VeteransPharmacotherapies for Alcohol and Substance Use Disorders Alliance · completed · Post Traumatic Stress Disorder, Opioid-use Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:30 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.